50 results on '"Suarez‐Cuartin, Guillermo"'
Search Results
2. Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity
3. Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona
4. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study
5. Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness
6. Inflamación local y sistémica en bronquiectasias. Endotipos y biomarcadores
7. Bronchiectasis-COPD Overlap Syndrome: Role of Peripheral Eosinophil Count and Inhaled Corticosteroid Treatment
8. Predicting individualized treatment effects of corticosteroids in community-acquired-pneumonia: a data-driven analysis of randomized controlled trials
9. Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial
10. Screening for latent tuberculosis infection in patients who are candidate for biological therapies in Spain? A multidisciplinary survey
11. ¿Cómo realizamos el cribado de infección tuberculosa latente en pacientes candidatos a terapias biológicas en España? Una encuesta multidisciplinar
12. Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis
13. Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis
14. Diagnostic challenges of bronchiectasis
15. Variability in Asthma Inflammatory Phenotype in Induced Sputum. Frequency and Causes
16. Variabilidad del fenotipo inflamatorio del asma en el esputo inducido. Frecuencia y causas
17. Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease
18. Outcomes of COVID-19 Patients Admitted to the Intermediate Respiratory Care Unit: Non-Invasive Respiratory Therapy in a Sequential Protocol
19. Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease
20. Clinical Characteristics of Bronchiectasis due to Transplant-Related Immunosuppression
21. Radio-histological correlation of lung features in severe COVID19
22. Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization
23. Secreted mucins and airway bacterial colonization in non-CF bronchiectasis
24. IPF cluster analysis highlights diagnostic delay and cardiovascular comorbidities association with outcome
25. Long-Term Antibiotics in Bronchiectasis
26. Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit
27. Lung Ultrasound Score to Predict Outcomes in COVID-19
28. A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile
29. Idiopathic pulmonary fibrosis cluster analysis highlights diagnostic delay and cardiovascular comorbidity association with outcome
30. Experience With Nintedanib in Severe Pulmonary Fibrosis Associated With Systemic Sclerosis: A Case Series
31. Impact of an Intermediate Respiratory Care Unit on Clinical Outcomes of COVID-19 Patients
32. Mapping IPF helps identify geographic regions at higher risk for disease development and potential triggers
33. Monounsaturated Fatty Acid diet associates less gastrointestinal adverse events of pirfenidone: phase IV clinical trial
34. Endotyping bronchiectasis through multi-omic profiling
35. Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients
36. Neutrophil Extracellular Traps are Increased in Severe Bronchiectasis and Reduced by Long-Term Azithromycin Treatment
37. Salivary immunity and lower respiratory tract infections in non-elite marathon runners
38. LSC - 2019 - Sputum protein profiling identifies a key role for neutrophil extracellular traps in exacerbations of bronchiectasis and treatment response
39. Antimicrobial peptides, disease severity and exacerbations in bronchiectasis
40. Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
41. Sputum protein profiling identifies a key role for neutrophil extracellular traps in exacerbations of bronchiectasis and treatment response
42. Antimicrobial peptides and airway bacterial colonization in bronchiectasis
43. Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study
44. Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis
45. Exacerbations of bronchiectasis requiring hospitalization; clinical characteristics and outcomes
46. Pseudomonas aeruginosaresistance patterns and clinical outcomes in hospitalized exacerbations of COPD
47. Corticosteroids and Pneumonia in COPD: A Dual Effect?
48. Case 6
49. Pseudomonas aeruginosa resistance patterns and clinical outcomes in hospitalized exacerbations of COPD.
50. Mapping IPF helps identify geographic regions at higher risk for disease development and potential triggers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.